Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients

Transplantation

Volumn 73, Issue 4, 2002, Pages 591-599

  Belperio, John A ^a   DiGiovine, Bruno ^a   Keane, Michael P ^a   Burdick, Marie D ^a   Xue, Ying Ying ^a   Ross, David J ^a   Lynch III, Joseph P ^a   Kunkel, Steven L ^a   Strieter, Robert M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLOGRAFT; ARTICLE; BRONCHIOLITIS; BRONCHOSCOPY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; GRAFT REJECTION; HUMAN; HUMAN TISSUE; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RECIPIENT;

EID: 0037181119     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200202270-00020     Document Type: Article

References (43)

1. Standardization of spirometry, 1994 update
2. IL-1 receptor antagonist (IL-1ra) expression, function, and cytokine-mediated regulation during mycobacterial and schistosomal antigen-elicited granuloma formation
3. Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB)
4. Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis: A compartmental analysis
5. Interleukin-1 receptor antagonist expression in sarcoidosis
6. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms
7. IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium
8. Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis
9. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung rejection study group
10. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group
11. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: Role of IL-8
12. Airway obstruction and bronchiolitis obliterans after lung transplantation
13. Biologic basis for interleukin-1 in disease
14. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist
15. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells
16. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2
17. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta: PGH2 does not contribute to impaired endothelium-dependent relaxation
18. Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat
19. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis
20. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant
21. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung
22. Circulating postinjury neutrophils are primed for the release of proinflammatory cytokines
23. Inhibition of microglial cell RANTES production by IL-10 and TGF-beta
24. Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures
25. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice
26. Adenovirus-mediated interleukin-10 gene transfer inhibits post-transplant fibrous airway obliteration in an animal model of bronchiolitis obliterans
27. Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice: Recipient environment alters graft rejection
28. Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice
29. Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability
30. Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
31. Elevated levels of interleukin-8 and transforming growth factorbeta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: Proinflammatory role of bronchial epithelial cells
32. Changes at the extracellular matrix during acute and chronic rejection in human liver transplantation
33. EGF and TGF-beta1 gene expression in chronically rejecting small bowel transplants
34. Chronic rejection of mouse kidney allografts
35. Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts
36. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation
37. The role of tumor necrosis factor in health and disease
38. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells
39. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis
40. The preliminary research on the relationship between TNF- and egg-induced granuloma and hepatic fibrosis of schistosomiasis japonica
41. Expression of cytokines and immune mediators during chronic liver allograft rejection
42. In situ expression of tumor necrosis factor-alpha, interfer-on-gamma, and interleukin-2 receptors in renal allograft biopsies